Literature DB >> 10391483

Axonal transport of ribonucleoprotein particles (vaults).

J Y Li1, W Volknandt, A Dahlstrom, C Herrmann, J Blasi, B Das, H Zimmermann.   

Abstract

RNA was previously shown to be transported into both dendritic and axonal compartments of nerve cells, presumably involving a ribonucleoprotein particle. In order to reveal potential mechanisms of transport we investigated the axonal transport of the major vault protein of the electric ray Torpedo marmorata. This protein is the major protein component of a ribonucleoprotein particle (vault) carrying a non-translatable RNA and has a wide distribution in the animal kingdom. It is highly enriched in the cholinergic electromotor neurons and similar in size to synaptic vesicles. The axonal transport of vaults was investigated by immunofluorescence, using the anti-vault protein antibody as marker, and cytofluorimetric scanning, and was compared to that of the synaptic vesicle membrane protein SV2 and of the beta-subunit of the F1-ATPase as a marker for mitochondria. Following a crush significant axonal accumulation of SV2 proximal to the crush could first be observed after 1 h, that of mitochondria after 3 h and that of vaults after 6 h, although weekly fluorescent traces of accumulations of vault protein were observed in the confocal microscope as early as 3 h. Within the time-period investigated (up to 72 h) the accumulation of all markers increased continuously. Retrograde accumulations also occurred, and the immunofluorescence for the retrograde component, indicating recycling, was weaker than that for the anterograde component, suggesting that more than half of the vaults are degraded within the nerve terminal. High resolution immunofluorescence revealed a granular structure-in accordance with the biochemical characteristics of vaults. Of interest was the observation that the increase of vault immunoreactivity proximal to the crush accelerated with time after crushing, while that of SV2-containing particles appeared to decelerate, indicating that the crush procedure with time may have induced perikaryal alterations in the production and subsequent export to the axon of synaptic vesicles and vault protein. Our data show that ribonucleoprotein-immunoreactive particles can be actively transported within axons in situ from the soma to the nerve terminal and back. The results suggest that the transport of vaults is driven by fast axonal transport motors like the SV2-containing vesicles and mitochondria. Vaults exhibit an anterograde and a retrograde transport component, similar to that observed for the vesicular organelles carrying SV2 and for mitochondria. Although the function of vaults is still unknown studies of the axonal transport of this organelle may reveal insights into the mechanisms of cellular transport of ribonucleoprotein particles in general.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391483     DOI: 10.1016/s0306-4522(98)00622-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Synaptic vesicle proteins and neuronal plasticity in adrenergic neurons.

Authors:  X E Hou; A Dahlström
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Axon viability and mitochondrial function are dependent on local protein synthesis in sympathetic neurons.

Authors:  Mi Hillefors; Anthony E Gioio; Marie G Mameza; Barry B Kaplan
Journal:  Cell Mol Neurobiol       Date:  2007-07-06       Impact factor: 5.046

3.  Proteomic Analysis of Connexin 43 Reveals Novel Interactors Related to Osteoarthritis.

Authors:  Raquel Gago-Fuentes; Patricia Fernández-Puente; Diego Megias; Paula Carpintero-Fernández; Jesus Mateos; Benigno Acea; Eduardo Fonseca; Francisco Javier Blanco; Maria Dolores Mayan
Journal:  Mol Cell Proteomics       Date:  2015-04-22       Impact factor: 5.911

Review 4.  Axonal regeneration after spinal cord injury in zebrafish and mammals: differences, similarities, translation.

Authors:  Katarina Vajn; Jeffery A Plunkett; Alexis Tapanes-Castillo; Martin Oudega
Journal:  Neurosci Bull       Date:  2013-07-28       Impact factor: 5.203

5.  Major vault protein is expressed along the nucleus-neurite axis and associates with mRNAs in cortical neurons.

Authors:  Constantinos D Paspalas; Casey C Perley; Deepa V Venkitaramani; Susan M Goebel-Goody; YongFang Zhang; Pradeep Kurup; Joanna H Mattis; Paul J Lombroso
Journal:  Cereb Cortex       Date:  2008-11-21       Impact factor: 5.357

6.  Recombinant major vault protein is targeted to neuritic tips of PC12 cells.

Authors:  C Herrmann; E Golkaramnay; E Inman; L Rome; W Volknandt
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

7.  Small noncoding vault RNA modulates synapse formation by amplifying MAPK signaling.

Authors:  Shuji Wakatsuki; Yoko Takahashi; Megumi Shibata; Naoki Adachi; Tadahiro Numakawa; Hiroshi Kunugi; Toshiyuki Araki
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

8.  Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

Authors:  Daniela Lötsch; Elisabeth Steiner; Klaus Holzmann; Sabine Spiegl-Kreinecker; Christine Pirker; Juraj Hlavaty; Helga Petznek; Balazs Hegedus; Tamas Garay; Thomas Mohr; Wolfgang Sommergruber; Michael Grusch; Walter Berger
Journal:  Oncotarget       Date:  2013-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.